The WACKER chemical group headquartered in Munich has acquired 100 percent of the shares of contract manufacturing company (CMO) ADL BioPharma. The shares were purchased from Kartesia, a financial investor with whom WACKER signed a corresponding agreement finalizing the transaction last week. Following WACKER’s purchase of fermentation assets in the northern Spanish city of León in 2016, the chemical group now owns the entire site. The acquisition of the company, employing a staff of roughly 300, expands WACKER’s fermentation capacities by approximately 2,000 cubic meters (gross volume) and adds additional capacities for recovery and purification processes. WACKER will continue and grow existing customer relationships maintained by ADL BioPharma in its capacity as CMO for fermentation-based products for the food, pharmaceutical and consumer goods industries. The purchase price for the acquisition exceeds €100 million.
For more information, visit www.wacker.com/presseinformationen
Innovations in Food (& Beverage) Technology is a quarterly magazine distributed globally both in Print and Digital formats. www.innovationsfood.com. Twitter: @Innovfoodtech. Instagram: @innovationsinfoodtechnology. Linkedin: www.linkedin.com/in/terry-prior52
